AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
4min chapter
Episode 24. ASCO/EHA 2023 Special: Updates on CAR T-cell Therapy in Myeloma
Blood Cancer Talks
The Non-ICANN's Neurotoxicity With Cilta Cell
Non-ICANN's neurotoxisities that have been described with Cilta cell, and also I believe in the package in sort of Ida Salen. The risk factors for this seem to be high tumor burden with growing disease at time of infusion. And so honestly, we don't know the best way to treat this when it occurs. Less than 1% is often a short course of steroids, either, you know, poll stacks or in some cases, hydro-salyumetrol,. IVIG is an immune modulating agent, and then time and just supportive care.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode